New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
16:43 EDTTSRXTrius Therapeutics announces publication of Phase 3 study in JAMA
Trius Therapeutics announced that the results from ESTABLISH 1, a Phase 3 study of tedizolid phosphate versus Zyvox completed in 2011, have been published in The Journal of the American Medical Association. As detailed in the JAMA article, tedizolid achieved the primary and all secondary endpoints in the ESTABLISH 1 trial. Approximately 42% of pathogens isolated at baseline in the study were methicillin resistant Staphylococcus aureus, the company said.
News For TSRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for TSRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use